Henry Ward Wolff

Henry Ward Wolff is a declared insider at 4 companies; the most frequent names are Sangamo Therapeutics, Inc, Portola Pharmaceuticals Inc and Abgenix Inc. We count 118 filings; the first trade dates from 24 March 2006 and the latest from 2 July 2020.

The open-market side counts 1 purchase for €21k alongside 46 sales for €3.8M. Sales outweigh purchases by €3.8M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 32 share grants and 34 option exercises.

The record was last updated on 2 July 2020 with a transaction (€288k) in Portola Pharmaceuticals Inc. The most recent open-market purchase was published on 30 August 2010, 5,899 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.